Study shows patient's own cells may hold therapeutic promise after reprogramming, gene correction
Monday, April 4, 2011 - 15:32
in Biology & Nature
Scientists from the Morgridge Institute for Research, the University of Wisconsin-Madison, the University of California and the WiCell Research Institute moved gene therapy one step closer to clinical reality by determining that the process of correcting a genetic defect does not substantially increase the number of potentially cancer-causing mutations in induced pluripotent stem cells.